Page 53 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 53

Development  of  a  Quality  Standard  for  Herbal  Medicine  of  Zingiber

               zerumbet Rhizome


                                                                                        3
                                 1
                                                                       2
                                                                                                         2
               Lih-Geeng Chen,  Muhammad Riki Shindi Praristiya,  Wei-Hsuan Su,  Che Chun Lin,
               and Ching-Chiung Wang*     ,2,3,4

               1  Department of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences,
                National Chiayi University
               2  PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei
                Medical University, Taipei
               3  Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University
               4  School of Pharmacy, College of Pharmacy, Taipei Medical University
               * E-mail: crystal@tmu.edu.tw

               Abstract

                  The rhizome of Zingiber zerumbet (L.) Smith, a common medicinal plant in Taiwan, has
               traditionally been used as a food additive with blood-activating and analgesic properties. Recent
               studies  have  confirmed  its  anti-inflammatory,  anti-arthritic,  and  neuroprotective  effects. To
               ensure consistent efficacy, this study established a quality control standard for  Z. zerumbet

               decoction pieces, using osteoarthritis as a pharmacological indicator. Major constituents were
               extracted by steam distillation and analyzed by GC-MS, followed by network pharmacology
               and  nitric  oxide  (NO)  inhibition  assays,  which  identified  zerumbone  and  3-O-
               methylkaempferol  as  principal  bioactive  compounds.  Zerumbone  exhibited  potent  NO-

               suppressing  activity,  and  commercial  sample  analysis  revealed  the  absence  of  3-O-
               methylkaempferol  in  some  products,  leading  to  the  selection  of  zerumbone  as  the  primary
               quality marker. Evaluation of fresh rhizomes harvested after cultivation for 8 months and 3
               years for every month indicated no significant influence of cultivation duration on zerumbone

               content, but clear seasonal variation, with post-autumn harvests yielding the highest levels (>25
               mg/g). Based on Taiwan Pharmacopoeia guidelines and Q test validation, it is recommended
               that  rhizomes  be  harvested  after  one  year  of  cultivation  in  the  following  autumn,  with  a
               minimum zerumbone content of 17.0 mg/g in decoction pieces. The efficacy of standardized

               rhizome  powder  was  further  confirmed  in  a  collagenase-induced  rat  osteoarthritis  model,
               demonstrating significant pain relief when appropriate zerumbone levels were present. This
               study establishes zerumbone as a reliable quality marker and provides a practical framework
               for the standardization of Z. zerumbet in herbal medicine.

               Keywords: Zingiber zerumbet; Zerumbone; Quality standard; Quality standard








                                                           31
   48   49   50   51   52   53   54   55   56   57   58